key: cord-0860366-w43ap207
authors: Shiri, Isaac; Arabi, Hossein; Salimi, Yazdan; Sanaat, Amirhossein; Akhavanallaf, Azadeh; Hajianfar, Ghasem; Askari, Dariush; Moradi, Shakiba; Mansouri, Zahra; Pakbin, Masoumeh; Sandoughdaran, Saleh; Abdollahi, Hamid; Radmard, Amir Reza; Rezaei‐Kalantari, Kiara; Ghelich Oghli, Mostafa; Zaidi, Habib
title: COLI‐Net: Deep learning‐assisted fully automated COVID‐19 lung and infection pneumonia lesion detection and segmentation from chest computed tomography images
date: 2021-10-28
journal: Int J Imaging Syst Technol
DOI: 10.1002/ima.22672
sha: eb22f37467982c5065bb36b9e4ccd30a867627b9
doc_id: 860366
cord_uid: w43ap207

We present a deep learning (DL)‐based automated whole lung and COVID‐19 pneumonia infectious lesions (COLI‐Net) detection and segmentation from chest computed tomography (CT) images. This multicenter/multiscanner study involved 2368 (347′259 2D slices) and 190 (17 341 2D slices) volumetric CT exams along with their corresponding manual segmentation of lungs and lesions, respectively. All images were cropped, resized, and the intensity values clipped and normalized. A residual network with non‐square Dice loss function built upon TensorFlow was employed. The accuracy of lung and COVID‐19 lesions segmentation was evaluated on an external reverse transcription‐polymerase chain reaction positive COVID‐19 dataset (7′333 2D slices) collected at five different centers. To evaluate the segmentation performance, we calculated different quantitative metrics, including radiomic features. The mean Dice coefficients were 0.98 ± 0.011 (95% CI, 0.98–0.99) and 0.91 ± 0.038 (95% CI, 0.90–0.91) for lung and lesions segmentation, respectively. The mean relative Hounsfield unit differences were 0.03 ± 0.84% (95% CI, −0.12 to 0.18) and −0.18 ± 3.4% (95% CI, −0.8 to 0.44) for the lung and lesions, respectively. The relative volume difference for lung and lesions were 0.38 ± 1.2% (95% CI, 0.16–0.59) and 0.81 ± 6.6% (95% CI, −0.39 to 2), respectively. Most radiomic features had a mean relative error less than 5% with the highest mean relative error achieved for the lung for the range first‐order feature (−6.95%) and least axis length shape feature (8.68%) for lesions. We developed an automated DL‐guided three‐dimensional whole lung and infected regions segmentation in COVID‐19 patients to provide fast, consistent, robust, and human error immune framework for lung and pneumonia lesion detection and quantification.

The recent pandemic of severe acute respiratory syndrome coronavirus 2 disease (COVID-19) is posing great health concerns globally. 1, 2 The COVID-19 pandemic has resulted in loss of lives, health, and economic issues. 3 Although a large number of trials have been conducted to produce vaccines and/or treat COVID-19, a specific vaccine or therapy is still lacking. 4, 5 For the diagnosis of COVID-19, reverse transcription-polymerase chain reaction (RT-PCR) is a high sensitive molecular test, but bears inherently a number of limitations. 6, 7 Furthermore, previous studies have indicated that thoracic computed tomography (CT) is a fast and highly sensitive approach for COVID-19 detection and management. 8, 9 In this regard, dedicated ultralow-dose CT scanning protocols were recently devised. 10 In connection with the use of CT in COVID-19 management, a wide range of qualitative and quantitative studies have been carried out for diagnostic, prognostic and longitudinal follow-up of patients. [11] [12] [13] In these studies, whole lungs or infectious lesions were analyzed and several patterns and features were found to have high diagnostic and prognostic value. [13] [14] [15] [16] [17] [18] However, accurate segmentation of lungs and infectious pneumonia lesions remains challenging. 19 Hence, segmentation is the main issue impacting the outcome of both qualitative and quantitative studies. 12, 19, 20 Although several segmentation approaches including manual delineation, semiautomated 21 and fully automated 20 techniques have been applied to CT images for COVID-19 management, they are still facing serious challenges to produce robust and dependable outcomes.

In medical image segmentation, particularly whole three-dimensional (3D) volumes definition and big data analysis, manual delineation requires experienced trained radiologists, is time consuming, labor-intensive, and suffers from interobserver and intraobserver variability concerns. 22, 23 Whole lung segmentation is a pivotal step for further analysis, including extraction of the percentage of infection, well aerated portion of the lung, and enabling radiomics and deep learning (DL) analysis of COVID-19 patients. 14, 17 Conventional algorithms, including rule-based and atlas-based, performed relatively well on normal and mild disease chest CT, but might fail in COVID-19 patients lung segmentation because of different stages of disease with different levels of severity. 19 Furthermore, developing a fully automatic tool for lung and pneumonia COVID-19 lesions is highly desired owing to rapid changes in appearance and manifestation at different stages of the disease. 13, 19 Artificial intelligence (AI) algorithms, particularly its two major subcategories, machine learning (ML), and DL, have been widely used for medical image analysis [24] [25] [26] [27] [28] [29] [30] [31] and more recently in the segmentation of lung and pneumonia infectious lesions from chest CT images of COVID-19 patients. 15 These studies reported that AI improved the accuracy of lesion detection/segmentation and reduced the bias associated with conventional approaches. In a study by Zheng and coworkers, 32 a weakly supervised DL algorithm was applied to chest CT images for automatic COVID-19 detection. Fan et al. 33 presented a COVID-19 lung infection segmentation deep network (Inf-Net) based on semisupervised learning. Furthermore, a number of DL algorithms, namely UNet, UNet++, V-Net, Attention-UNet, Gated-UNet, and Dense-UNet were used for COVID-19 lesion detection and segmentation from chest CT images. 34, 35 CT images are commonly acquired on various scanner models using different imaging protocols, and as such, the resulting datasets are heterogeneous, which might lead to inaccuracy in the developed models. Training a robust and generalizable DL model requires a large clean annotated dataset. 36 Owing to the relatively recent outbreak of COVID-19 pandemic, producing a large labeled COVID-19 image dataset is impractical. Transfer learning (TL) has received attention to address the lack of large datasets for the implementation of machine/DLbased algorithms. 37, 38 Various TL-based strategies were used for transferring knowledge from different domains, including natural images to medical images to develop more robust and generalizable models. 38 In the present study, we developed a DL-based automated detection and segmentation of lung and COVID-19 pneumonia infectious lesions (COLI-Net) from chest CT images. In this work, large lung and COVID-19 lesions datasets and TL used to train a residual network (ResNet) for lung and pneumonia infectious lesions segmentation.

For lung and COVID-19 lesions segmentation, we prepared 2368 (347 259, 2D slices) and 190 (17 341, 2D slices) multicentric and multivendor volumetric CT images with lung and COVID-19 lesion segmentations.

For lung segmentation training, we used 2298 chest CT exams (328 0 205, 2D slices) with different pathologies from different centers, including 800 exams of normal subjects without any lung abnormalities from Iran Cen-ter#1 (81 0 347, 2D slices); 400 images of non-small cell lung carcinoma patients from Cancer Imaging Archive (TCIA) [39] [40] [41] (48 0 568, 2D slices); 200 non-COVID-19 pneumonia (49 0 465, 2D slices); and 898 (148 0 825, 2D slices) RT-PCR positive COVID-19 patients from Iran Center#2. All lung segmentations were performed using a regiongrowing algorithm followed by manual verification and amendment by an experienced radiologist.

For COVID-19 lesions segmentation training, we used 120 (9557, 2D slices) RT-PCR positive image datasets, including 90 (8338, 2D slices) datasets from three different centers in Iran (Centers#1, #2, #3) where the infectious lesions were manually segmented by experienced radiologists, in addition to 30 (1250, 2D slices) CT exams from Russia. 42 Lesions were segmented manually for the local dataset whereas these segmentations were provided by data providers for the external dataset. [42] [43] [44] 

Prior to network training, all images were cropped without losing important information (parts of lungs) and resized to 296 Â 216 matrix size. In the first step of intensity normalization, voxel intensities in the entire dataset were clipped between À1024 and 300 HUs to reduce the dynamic range of the intensity of CT images. This range of HUs covers air, lung tissue, fat, soft-tissue, and calcifications in the lung. Only bony structures will be suppressed, which are irrelevant to lung and lesion segmentations. Hence, we found this range of HUs optimal for ML-based lung and lesion segmentation. Moreover, to further reduce the dynamic range of voxel intensities, CT images were normalized with an empiric factor equal to 1000 to keep the original dynamic intensity range and put the bulk of CT intensity within the range of 0-1 HU.

The ResNet proposed by Li et al. 45, 46 built upon Ten-sorFlow was used for lung and COVID-19 lesions segmentation. The ResNet is composed of 20 convolutional layers where different dilation factors were used for different levels of feature extraction (zero dilatation factor for low-level, two dilatation factors for medium-level, and four dilatation factors for high level). Every two layers were linked together with residual connections (Figure 1 ). Non-square Dice was used as loss function, and Figure 1 provides descriptive detail of ResNet.

Lung and COVID-19 lesions training was performed on 2D slices owing to the wide variability in slice thicknesses across the datasets from the different centers. We used the following hyperparameters for model training: loss function = non-square Dice, learning rate = 0.001, optimizer = Adam, decay = 0.0001, batch size = 32, and weights regression type = L2norm, drop out = 0.5, and number of epochs = 300. For lung segmentation training, we used 2178 3D CT images (347 259, 2D slices). For COVID-19 lesions segmentation, we used pretrained lung segmentation network as initial weights followed by finetuning for lesion segmentation of 120 3D CT images (9557, 2D slices). Body fine-tuning approaches were used for TL where all pretrained weights of lung segmentation were used as initial weights for lesion segmentation. The quantitative assessment of segmentations was performed independently on RT-PCR positive COVID-19 datasets from different centers, including 20 CT exams (2214, 2D slices) from Center#1 (Iran1); 10 exams (2552, 2D slices) from Center#2 (Iran2); 20 exams (1250, 2D slices) from center#3 (Russia) 42 ; 10 exams (939, 2D slices) from Cen-ter#4 (China) 43, 44 ; and 10 exams (829, 2D slices) from center#5 (Italy*). 44 Training datasets were split into training (80%) and validation (20%) sets. Overall, the evaluation was performed on 7333 2D slices from different centers. Data splitting into training and test sets was performed based on 3D image of patients without overlap between the training and test sets. All evaluations were performed in 3D mode.

To evaluate the performance of image segmentation, we calculated Dice similarity coefficient (Equation (1)), Jaccard index (Equation (2)), false negative (Equation (3)), false positive (Equation (4)), mean surface distance (Equation (5)), and mean Hausdorff distance (Equation (6)). In addition, different volume indices were exploited to quantify the portion of infection, including relative volume difference (%), relative volume difference of lesion/lung relative volume (%) (Equation (7)), absolute relative volume difference (%) (Equation (8)), and absolute relative volume difference of lesion/lung relative volume (%). Hounsfield unit (mean) relative difference (%), and Hounsfield unit (mean) absolute relative difference (%) were calculated for lungs and COVID-19 lesions from different segmentations of CT images. In addition, we evaluated the impact of the segmentation on 17 first-order and 10 shape radiomic features in both lungs and COVID-19 lesions. The list of radiomic features is presented in Supplemental Table 1 .

where d p, G ð Þ is the distance between a point p belonging to the surface of a 3D surface predicted image (P) and its closest distance between the two surfaces P and G (ground truth). 

3 | RESULTS Overall, there is good agreement between manual and predicted lung and infectious lesions segmentation in the different datasets. Despite the variability of the subjects among the different centers, COLI-Net performed consistently well in multicentric and multiscanner setting. What stands out from these results is that COLI-Net can detect and segment infectious regions (within lesion segmentation) while excluding arteries and tracheae in lung segmentation. Table 1 summarizes segmentation quantification metrics for lungs and COVID-19 lesions. It can be seen that the mean Dice coefficients were 0.98 ± 0.011 (95% CI, 0.98-0.99) and 0.91 ± 0.038 (95% CI, 0.90-0.91) for lung and lesions segmentation, respectively. The mean Jaccard index was 0.97 ± 0.022 (95% CI, 0.97-0.97) and 0.83 ± 0.062 (95% CI, 0.82-0.84) for lung and COVID-19 lesions segmentation, respectively. Lung segmentation in Russia datasets exhibited better results compared to the other centers/datasets. This might be attributed to the homogeneity and mild severity of the lesions in this dataset. Supplemental Tables 2-7 summarize lung and lesion segmentation quantification metrics for different external validation sets. positive, average Hausdorff distance, and mean surface distance for lung and lesions. Descriptive statistics of relative volume (lesion/lung) indices are presented in Table 3 . A relative error of 0.22 ± 6.3 (95% CI, À0.95 to 1.4) and absolute relative error of 4.7 ± 4.2 (95% CI, 3.9-5.5) were achieved for relative volume (lesion/lung). Supplemental Tables 12 and 13 summarize the results obtained for the relative volume (lesion/lung) index for different external validation sets. Figure 6 depicts boxplot of manual and predicted relative volume lesion/lung differences (%) and absolute/relative error of lesion/lung relative volume errors (%) for different external validation sets. Figure 7 presents heatmap of the mean relative error of first-order and histogram shape radiomic features in the lung and lesions for different validation sets. Most radiomic features exhibited a mean relative error less than 5% with the highest mean relative error for the lung being À6.95% for range first-order feature and least axis length shape feature (8.68%) in lesions. The heatmap of the mean absolute relative error is depicted in Supplemental Figure 20 .

Chest CT imaging has emerged as a complementary tool for COVID-19 early diagnosis and longitudinal follow-up. 8 However, a number of challenges still need to be addressed for the accurate diagnosis of COVID-19 and its differentiation from other lung diseases, such as viral and bacterial pneumonia and other respiratory diseases. 17 In this regard, several AI-based solutions exhibiting different levels of accuracy and robustness were proposed and evaluated. 14, 17 Another challenging problem that arises in the domain of quantitative analysis of CT images in clinical practice is lung and pneumonia infectious lesions segmentation. 19 At the outset, different complex manifestations (appearance, size, location, boundaries and contrast) of infectious lesions, including consolidation, reticulation, and ground-glass opacity at different stages of the disease (longitudinal changes in the same patients) have been observed. 13 Furthermore, providing ground truth segmentation for infectious lesion segmentation is challenging owing to interobserver/intraobserver variability, noisy annotations, and the long processing time. 19 F I G U R E 5 Box plots comparing various quantitative imaging metrics for COVID-19 lesions segmentation, including Dice coefficient, Jaccard index, Hounsfield units (mean) relative difference (%), and relative volume difference (%) Previously developed atlas, 47 rule, 48 and hybrid (atlas and rule) 49 based algorithms for lung segmentation have shown acceptable performance on normal lungs and in the presence of mild pathogens (low density), such as emphysema. 50 However, they presented limited performance in severe conditions (high density), including pleural effusion, atelectasis, consolidation, fibrosis, and pneumonia. 51 Recent developments in the field of ML have led to a renewed interest in automatic lung segmentation. However, most seminal works in this area used a limited training dataset, predominantly containing normal cases or focusing on one class of pathogeneses, which could impact generalizability for unseen/nondiagnosed test datasets. 52 In the present study, we applied DL algorithms and TL on CT images obtained from different imaging centers to detect and segment the whole lung and pneumonia infected regions in COVID-19 patients.

A number of previous works attempted to develop automated segmentation algorithms for lung and infectious lesions in COVID-19 CT images. Hofmanninger et al. 51 developed models for lung segmentation and reported a Dice coefficient of 0.98 ± 0.01 for different pathological states (atelectasis, fibrosis, mass, pneumothorax, and trauma). They concluded that diversity in the training dataset is more important than the DL algorithms. Müller et al. 53 implemented a 3D U-Net using data augmentation for generating image patches during 56 ; and U-Net++ (lung: 0.986, lesions: 0.681). 57 The mean Dice coefficient for lung and lesions segmentation for different external validation sets used in our work were 0.98 ± 0.011 and 0.91 ± 0.038, respectively. Chen et al. 58 used the residual attention U-Net for multi-class segmentation of CT images, achieving a Dice coefficient of 0.94 for infectious lesions segmentation. Zhou et al. 35 used a modified U-net network through spatial and channel attention mechanisms along with focal Tversky loss in the training process for improving small lesions segmentation. The results were evaluated on F I G U R E 7 Mean relative error of different first-order and shape radiomic features for different datasets in lung and infection regions 427 slices achieving a Dice coefficient of 0.83. Elharrouss et al. 59 adopted an encoder-decoder for infectious lesions segmentation using 20 clinical studies from the Italian Society of Medical and Interventional Radiology to report a Dice coefficient of 0.786. They compared the results with U-Net (Dice: 0.439), 60 Attention-UNet (Dice: 0.583), 61 Gated-UNet (Dice: 0.623), 62 Dense-UNet (Dice: 0.515), 63 U-Net++ (Dice: 0.422), 57 and Inf-Net (Dice: 0.739). 33 Wang et al. 64 proposed a robust algorithm for COVID-19 infectious lesions segmentation from CT images (COPLE-Net) designed to learn from noisy labeled data. The algorithm relies on noise-robust Dice loss and mean absolute error loss for generalized Dice loss for robust segmentation of noisy datasets and a modified version of U-Net to better handle infectious lesion segmentation with various manifestations and scales. 67 Our proposed COLI-Net approach showed good performance compared to previous studies with a Dice coefficient of 0.91 ± 0.038 (95% CI: 0.90-0.91) and RVE of 0.38 ± 1.2% (95% CI: 0.16-0.59) for pneumonia infectious lesions.

A large labeled dataset is required to build a robust and generalizable model while avoiding overfitting. Previous studies attempted to transfer the knowledge from natural to medical imaging domain, leading to improved accuracy by addressing the issue of limited datasets. 37, 38 TL was recently applied for the detection and classification of COVID-19 using chest x-ray and CT images. 68, 69 More recently, Wang et al. 70 applied four TL methods on COVID-19 CT images for the segmentation of infectious lesions using 3D U-Net. The information was transformed from cancer and pleural effusion data to COVID-19 lesion segmentation. The Dice coefficient increased from 0.673 ± 0.22 to 0.703 ± 0.20 after TL. 70 They concluded that the transferability of non-COVID-19 data improved the quality of COVID-19 lesion segmentation to build a robust segmentation model. In our study, we exploited TL from a large multicentric lung labeled dataset with various pathologies to overcome the shortcomings of infectious lesion segmentation.

Li et al. 71 used thick-section chest CT images of 531 COVID-19 patients for automatic segmentation of lesions using 2.5D U-net to achieve Dice coefficients of 0.74 ± 0.28 and 0.76 ± 0.29 with respect to manual delineation performed by the two radiologists. The interobserver variability measured by the Dice metric was 0.79 ± 0.25 between two radiologists. They calculated two imaging biomarkers, including the percentage of infection and average infectious HU for severity and progression assessment, resulting in AUC of 0.97. Thick-section CT imaging was recommended for high-pitch scans to decrease the acquisition time and motion artifacts (due to breath holding) and reduce radiation doses to patients. 10, 72 In our dataset, various slice thicknesses (1-8 mm) have been included to train a robust network against this parameter, which highly impacts image manifestations. The relative error of volume difference for the percentage of infections (lesion/lung) and relative mean HU Diff (%) were 0.22 ± 6.3% (95% CI: À0.95 to 1.4%) and À0.18 ± 3.4% (95% CI: À0.8 to 0.44%), demonstrating the high accuracy of COLI-Net for biomarker generation.

Potential foreseen applications are not limited to the detection and segmentation but could be useful in providing diagnostic and prognostic parameters calculated using lung and infections segmentation to estimate the percentage of infections, and enabling advanced image processing in COVID-19 patients. The existing body of research on pneumonia suggests that the pneumonia severity index (PSI) can potentially be used as a severity marker. 73 A recent study classified COVID-19 patients into severe and nonsevere patients based on PSI calculated using CT images. 74 Different DL algorithms and radiomics analysis approaches using CT images have been examined recently for developing diagnostic (discriminating COVID-19 from bacterial/viral pneumonia) and prognostic (survival, hospital stay, intensive care unit [ICU] admission, risk of outcome) models, which require lung and lesion segmentation. 17 Moreover, calculating the percentage of infection and well-aerated regions in the lung are frequently performed through visual assessment or by simply calculating HU values in the lungs, which is not only time-consuming but also lacks accuracy.

The established model exhibited noticeable performance variation across different COVID-19 patients collected from different countries, centers, with different patient backgrounds, and stages of the disease. Since the quality of CT images depends directly on the scanner model, imaging protocol (tube voltage, tube current, pitch factor, etc.), and reconstruction algorithm, we employed various datasets from different centers to cover a large variability.10,72 Although the proposed algorithm was evaluated using a multicenter, multiscanner, multinational dataset and patients with a diverse background, stages of the disease, a full-scale adaptation of this model requires further clinical investigation and fine-tuning to the specific image acquisition parameters of a center. This framework provides multiple imaging biomarkers for COVID-19 patients to facilitate the assessment of their clinical relevance in diagnostic (discriminating COVID-19 from bacterial/viral pneumonia) and prognostic (survival, hospital stay, ICU admission, risk of outcome) applications. Further development should involve implementing lung lobes segmentation to calculate all potential imaging biomarkers at the lobes level. In this study, we used only the ResNet architecture for model evaluation. However, further evaluations should be conducted to compare different models, including UNet, VNet, and GAN architectures.

We set out to develop an automated algorithm capable of segmenting 3D whole lung and infected regions in COVID-19 patients from chest CT images using DL techniques to enable fast, consistent, robust, and human error immune framework for lung and pneumonia lesion detection and delineation. Owing to the complex nature of the problem and high variability in lesion manifestation, TL from whole lungs to pneumonia infection lesions was proposed and implemented to enrich specific COVID-19 pneumonia features identification from clinical studies. Moreover, a multicentric and multiscanner dataset was collected for the development of the DL model to establish an automated and generalizable platform for efficient COVID-19 patients management. The developed AI model was evaluated using a wide range of COVID-19 patients of diverse populations with different stages of the disease from multiple centers around the world to enable big data analysis of COVID-19 for automated progression/regression assessment of pneumonia lesions in follow-up studies, provide diagnostic and prognostic metrics, and enable further advanced image processing.

ACKNOWLEDGMENT This work was supported by the Swiss National Science Foundation under grant SNRF 320030_176052. Open access funding provided by Universite de Geneve.

The authors declare no conflicts of interest.

Isaac Shiri and Hossein Arabi are the co-first authors of this paper. Mostafa Ghelich Oghli and Habib Zaidi contributed to the study conception and design. Isaac Shiri and Hossein Arabi designed, implemented, and evaluated the image segmentation and ML framework. Yazdan

Salimi, Amirhossein Sanaat, Azadeh Akhavanallaf, Ghasem Hajianfar, Dariush Askari, Shakiba Moradi, Zahra Mansouri, Masoumeh Pakbin, Saleh Sandoughdaran, Hamid Abdollahi, Amir Reza Radmard, and Kiara Rezaei-Kalantari collated the datasets. Habib Zaidi contributed to the study conception and design, initial draft of the manuscript and supervision and funding of this work. All authors contributed to the data preparation and revision of the manuscript for important content.

The data supporting the findings of this study are not available.

ORCID Isaac Shiri https://orcid.org/0000-0002-5735-0736 Habib Zaidi https://orcid.org/0000-0001-7559-5297 ENDNOTE

A novel coronavirus from patients with pneumonia in China

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention

The socio-economic implications of the coronavirus pandemic (COVID-19): a review

The COVID-19 vaccine development landscape

Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review

Sensitivity of chest CT for COVID-19: comparison to RT-PCR

Patients with RT-PCR-confirmed COVID-19 and normal chest CT

Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases

Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT

Ultra-low-dose chest CT imaging of COVID-19 patients using a deep residual neural network

Diagnostic performance of chest CT for SARS-CoV-2 infection in individuals with or without COVID-19 symptoms

A fully automatic deep learning system for COVID-19 diagnostic and prognostic analysis

Automated assessment of CO-RADS and chest CT severity scores in patients with suspected COVID-19 using artificial intelligence

Radiomics analysis of computed tomography helps predict poor prognostic outcome in COVID-19

Automated detection and forecasting of covid-19 using deep learning techniques: a review

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

Artificial intelligence-enabled rapid diagnosis of patients with COVID-19

Clinically applicable AI system for accurate diagnosis, quantitative measurements, and prognosis of covid-19 pneumonia using computed tomography

Review of artificial intelligence techniques in imaging data acquisition, segmentation and diagnosis for covid-19

Automated quantification of CT patterns associated with COVID-19 from chest CT

Segmentation and evaluation of COVID-19 lesion from CT scan slices-a study with Kapur/Otsu function and cuckoo search

Medical image analysis using convolutional neural networks: a review

Deep learning techniques for medical image segmentation: achievements and challenges

Deep-JASC: joint attenuation and scatter correction in whole-body 18 F-FDG PET using a deep residual network

Standard SPECT myocardial perfusion estimation from half-time acquisitions using deep convolutional residual neural networks

The promise of artificial intelligence and deep learning in PET and SPECT imaging

Whole-body voxelbased internal dosimetry using deep learning

Personalized brachytherapy dose reconstruction using deep learning

Fully automated gross tumor volume delineation from PET in head and neck cancer using deep learning algorithms

Deep learning-based auto-segmentation of organs at risk in high-dose rate brachytherapy of cervical cancer

Automatic fetal biometry prediction using a novel deep convolutional network architecture

A weakly-supervised framework for COVID-19 classification and lesion localization from chest CT

Inf-net: automatic COVID-19 lung infection segmentation from CT images

COVID-19 chest CT image segmentation-a deep convolutional neural network solution

An automatic COVID-19 CT segmentation network using spatial and channel attention mechanism

How much data is needed to train a medical image deep learning system to achieve necessary high accuracy

Generalizing deep learning for medical image segmentation to unseen domains via deep stacked transformation

Med3d: transfer learning for 3d medical image analysis

PleThora: pleural effusion and thoracic cavity segmentations in diseased lungs for benchmarking chest CT processing pipelines

The cancer imaging archive (TCIA): maintaining and operating a public information repository

Data from NSCLCradiomics. The cancer imaging archive

chest CT scans with covid-19 related findings dataset

Towards efficient covid-19 CT annotation: a benchmark for lung and infection segmentation

COVID-19 CT Lung and Infection Segmentation Dataset

On the compactness, efficiency, and representation of 3D convolutional networks: brain parcellation as a pretext task

Tensorflow: large-scale machine learning on heterogeneous distributed systems

Toward automated segmentation of the pathological lung in CT

Automated lung segmentation from HRCT scans with diffuse parenchymal lung diseases

Automated segmentation of lungs with severe interstitial lung disease in CT

Automatic lung segmentation in HRCT images

Automatic lung segmentation in routine imaging is primarily a data diversity problem, not a methodology problem

Autosegmentation for thoracic radiation treatment planning: a grand challenge at AAPM 2017

Automated chest CT image segmentation of COVID-19 lung infection based on 3D U

FD-FCN: 3D fully dense and fully convolutional network for semantic segmentation of brain anatomy

3D U-net: learning dense volumetric segmentation from sparse annotation

V-net: fully convolutional neural networks for volumetric medical image segmentation

Unet++: a nested u-net architecture for medical image segmentation. Deep Learning in Medical Image Analysis and Multimodal Learning for Clinical Decision Support

Residual attention U-net for automated multi-class segmentation of COVID-19 chest CT images

An encoderdecoder-based method for COVID-19 lung infection segmentation

U-net: convolutional networks for biomedical image segmentation

Attention u-net: learning where to look for the pancreas

Attention gated networks: learning to leverage salient regions in medical images

DenseUNet: hybrid densely connected UNet for liver and tumor segmentation from CT volumes

A noise-robust framework for automatic segmentation of COVID-19 pneumonia lesions from CT images

No new-net. Paper presented at: International MICCAI Brainlesion Workshop

Recalibrating fully convolutional networks with spatial and channel "squeeze and excitation" blocks

Espnetv2: a lightweight, power efficient, and general purpose convolutional neural network

Classification of the COVID-19 infected patients using Den-seNet201 based deep transfer learning

COVID-19 pneumonia diagnosis using a simple 2D deep learning framework with a single Chest CT image: model development and validation

Does non-COVID-19 lung lesion help? Investigating transferability in COVID-19 CT image segmentation

From community acquired pneumonia to COVID-19: a deep learning based method for quantitative analysis of COVID-19 on thick-section CT scans

Chest CT practice and protocols for COVID-19 from radiation dose management perspective

A prediction rule to identify low-risk patients with community-acquired pneumonia

Lung infection quantification of COVID-19 in CT images with deep learning

COLI-Net: Deep learning-assisted fully automated COVID-19 lung and infection pneumonia lesion detection and segmentation from chest computed tomography images